EntreMed Commences Phase 2 Clinical Trial Combining Panzem NCD and Temodar in Brain Cancer Patients
There are 1 comment on the Med Ad News story from May 31, 2007, titled EntreMed Commences Phase 2 Clinical Trial Combining Panzem NCD and Temodar in Brain Cancer Patients. In it, Med Ad News reports that:
EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the commencement of a Phase 2 combination study with ... via Med Ad News
Join the discussion below, or Read more at Med Ad News.
#1 Jun 7, 2007
Hi, I'm Bill Corrigan, board member of the Little Louie Foundation ~ Helping to fight pediatric brain cancer.
See the story about our foundation's $10,000 donation to cancer researcher Dr. Linda Van Aelst!
Visit http://billcorriganwhatsnew.blogspot.com/ today!
Tell your colleagues about how we can help researchers!
Add your comments below
Copyright © 2016 Topix LLC